Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), whic…
Government Awards Analysis Beta
It's important to keep an eye on government contracts, because they can make up a substantial portion
of total sales for your researched company.
The Data for the government spending analysis is directly sourced from the
US gov. application interface.
Obligations Over-Time
Cellectar Biosciences, Inc. has no obligation with a government/award agency.
Latest Obligations
Spending By Type
Cellectar Biosciences, Inc. can't present spending by time.
Get PRO Today
With PRO you will unlock all insights related to government awards of Cellectar Biosciences, Inc..